Deutsche Diabetes Forschungsgesellschaft e.V.

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Type 2 diabetes2 trials
• High blood pressure1 trial

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Recruiting2 trials

Lead sponsor

• Boehringer Ingelheim1 trial
• Marc Donath1 trial

Running trials

• Recruiting

  EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  NCT07064473· Phase 3· Boehringer Ingelheim· Source

• Recruiting

  Dapansutrile in Diabetes and Diabetes-Related Complications - Dapan-Dia

  NCT06047262· Phase 2· Marc Donath· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Type 2 diabetes2 recruiting
• High blood pressure1 recruiting